With SAP’s end of mainstream maintenance for ECC approaching in 2027, organizations are under pressure to define their migration plan. New insights from Info-Tech Research Group show that relying too heavily on implementation partners to make strategic migration decisions can increase the risk of cost overruns, project delays, and outcomes that fail to reflect business priorities. The firm’s Build Your S/4HANA Migration Plan blueprint helps SAP migration teams evaluate migration options and trade-offs, lead critical decisions, and establish direction before engaging technical partners.

ARLINGTON, Va., Sept. 15, 2026 /PRNewswire/ — SAP users preparing to migrate from ECC to S/4HANA face one of the largest technology transformations many organizations will undertake. While these initiatives often require outsourced technical expertise, the most critical migration decisions remain the organization’s responsibility. According to recent insights published in Info-Tech Research Group’s Build Your S/4HANA Migration Plan blueprint, many teams enter implementation without fully understanding how strategic migration decisions affect long-term business outcomes.

Info-Tech’s research recognizes the important role that implementation partners play in S/4HANA migrations. However, it also emphasizes that strategic decisions must remain with the organization. While partners provide essential technical expertise, they may not have the full business context needed to determine priorities, transformation goals, or acceptable trade-offs. These decisions shape every stage of migration, from deployment and migration strategies to governance and organizational change. Without a clear understanding of their long-term implications, organizations risk cost overruns, delays, and reduced business value.

“Most organizations do not run ERP transformations often enough to build deep internal experience,” says Mia Scherba, research analyst at Info-Tech Research Group. “Implementation partners are critical to execution, but they cannot determine what the business should prioritize or which trade-offs it can accept. Those choices need to be owned internally because they shape cost, complexity, and long-term value well beyond the migration.”

Key Factors That Increase S/4HANA Migration Risk

Info-Tech’s research highlights several planning challenges that consistently affect S/4HANA migration outcomes:

Migration complexity is underestimated. Treating S/4HANA as a technical upgrade rather than a full ERP transformation leads organizations to overlook the effort required on customizations and integrations.Critical decisions are made independently. Migration strategy, deployment method, technical complexity, and organizational readiness influence one another. Optimizing one decision without evaluating the others can introduce unintended constraints and trade-offs.Implementation partners are expected to define business direction. While external partners provide essential technical expertise, they cannot determine organizational priorities and acceptable trade-offs.Change management receives insufficient attention. Successful migrations depend not only on technical execution but also on organizational readiness and user adoption.

Info-Tech’s Three-Phase Methodology for Building an S/4HANA Migration Plan

To help organizations establish direction before technical work begins, Info-Tech’s Build Your S/4HANA Migration Plan blueprint guides SAP migration teams through three planning phases.

Discover the Current SAP Landscape. Assess internal capabilities, strategic intent, organizational readiness, and technical complexity to establish a realistic starting point.Define the Migration Plan. Evaluate deployment methods, migration strategies, and the trade-offs associated with each option to identify a combination that aligns with organizational capacity and priorities.Prepare for Migration. Formalize governance, define rollout expectations, and document the decisions that implementation partners will use to execute the migration.

The blueprint also includes a S/4HANA Project Management Worksheet, S/4HANA Complexity Assessment, S/4HANA Decision Guide, and S/4HANA Migration Readiness Brief. These resources help organizations assess their current environment, evaluate migration scenarios, document planning decisions, and communicate a clear implementation strategy before engaging technical delivery partners.

For exclusive and timely commentary from Info-Tech’s experts, including Mia Scherba, and access to the complete Build Your S/4HANA Migration Plan blueprint, please contact pr@infotech.com.

About Info-Tech Research Group

Info-Tech Research Group is the “get things done” partner for over 30,000 IT, HR, and marketing leaders worldwide. The fastest growing research and advisory firm, Info-Tech enables leaders to make well-informed decisions and transform their organizations through AI, strategic foresight, step-by-step methodologies, practical tools, industry-leading advisory, and training programs. For nearly 30 years, tens of thousands of private and public organizations have trusted Info-Tech to lead their most important initiatives through periods of change and deliver outcomes that truly matter.

To learn more about Info-Tech’s HR research and advisory services, visit McLean & Company, and for data-driven software buying insights and vendor evaluations, visit the firm’s SoftwareReviews platform.

Media professionals can register for unrestricted access to research across IT, HR, and software, and hundreds of industry analysts through the firm’s Media Insiders program. To gain access, contact pr@infotech.com.

For information about Info-Tech Research Group or to access the latest research, visit infotech.com and connect via LinkedIn and X.

View original content to download multimedia:https://www.prnewswire.com/news-releases/s4hana-migration-risk-rises-when-strategic-decisions-are-left-to-implementation-partners-info-tech-research-group-finds-302879284.html

SOURCE Info-Tech Research Group

SECAUCUS, N.J., Sept. 15, 2026 /PRNewswire/ — As consumers increasingly turn to social media and AI-powered search for answers about sensitive skin, Laboratoires Pierre Fabre — the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical laboratories — is elevating Avène as the platform for a necessary kind of influence: dermatologist-led education.

Now in its third year, Dermfluencer University is hosted at the Science of Skin Summit, an annual educational event founded by Dr. Patricia Farris and Dr. Ted Lain dedicated to the science, clinical research and emerging innovations behind dermatology and skincare. The program equips board-certified dermatologists with insights, tools and training to create engaging, science-backed content for today’s digital-first skincare consumer.

As a clinically proven brand, Avène recognizes that today’s patients aren’t just in the dermatologist’s office, they’re online, searching for answers before they ever book an appointment. By equipping dermatologists to meet them there, Avène is working to reach more patients and help them navigate their skin concerns with credible, engaging, science-backed guidance.

“Consumers are now turning to AI and social platforms with the same questions they once reserved for their dermatologist,” said Romina Laraia, VP of Consumer, Patient and Professional Activation. “As a dermocosmetics brand, we have a responsibility to prioritize consumers both online and in the dermatologist office. Dermfluencer University was created to help ensure the answers they find are rooted in clinical expertise and not misinformation or viral trends.”

With a combined social following of over 6.5 million, this year’s Dermfluencer University participants represent some of the most trusted voices in skincare education today, including, Mimi Banks, founder of MB Social; Ian Michael Crumm, founder of Boys in Beauty; Leslie Ann Hall, founder of Iced Media; Britt Fallon, Director of Beauty at NewBeauty; Dr. Jenny Liu (@derm.talk); Dr. Maren Locke (@thebudgetdermatologist); Dr. Kunal Malik (@dermdocmalik); Dr. Neera Nathan (@dermatologysurgeon); Dr. Dustin Portela (@drdustinportela); Vivian Sullivan, Sr. Partner Lead at Google; and Dr. Lindsey Zubritsky (@dermguru). Attendance is expected to be the strongest yet.

“Every day, I see skincare advice go viral with no clinical basis,” said Dr. Lindsey Zubritsky. “Dermfluencer University gives dermatologists the tools to compete in the same feed with content that’s engaging, accurate and grounded in science.”

“Patients are making skincare decisions based on short-form videos, sometimes before they ever see a dermatologist,” said Dr. Jenny Liu. “We need more dermfluencers to meet them where they are, with information they can trust.”

With dermatologist and HCP partners at the core of their strategy, Avène continues to expand these partnerships across three key pillars: online, in-office and at retail. Together, these efforts bring science-backed education and Avène’s sensitive skin solutions closer to patients wherever they are.

For more information about Avène sensitive skincare, dermatologist-recommended skincare and Dermfluencer University, follow @aveneusa on Instagram and TikTok or visit www.aveneusa.com.

Note: High-resolution images, interviews, and product samples are available upon request.

ABOUT EAU THERMALE AVÈNE
With more than 275 years of expertise rooted in dermatology and hydrotherapy, Eau Thermale Avène by Pierre Fabre is dedicated to caring for sensitive skin and is recommended by dermatologists worldwide. Formulated with dermatologist-grade ingredients and Avène Thermal Spring Water, the brand offers clinically proven solutions designed to soothe, soften and calm even the most sensitive skin. Dermatologists are involved from product concept and development through testing to help create safe, high-tolerance formulas, and Avène products are non-comedogenic.

ABOUT LABORATOIRES PIERRE FABRE
Laboratoires Pierre Fabre is the world’s second-largest dermo-cosmetics company and one of Europe’s leading pharmaceutical Laboratoires. Its Dermo-cosmetics & Personal Care portfolio brings together major international brands such as Eau Thermale Avène, Dexeryl, Ducray, Klorane, A-Derma, René Furterer, Même Cosmetics, Darrow, and Elgydium. The Pharma activity covers 5 main therapeutic fields: oncology, dermatology, rare diseases, primary care and family health care.

In 2025, Laboratoires Pierre Fabre generated €3.2 billion euros in revenue, 71% of which came from international sales across 130 territories. Based in southwest France since its creation and manufacturing nearly 90% of its products in France, Laboratoires Pierre Fabre employs 10,000 people worldwide. R&D investments increased by 14% compared with the previous year, reaching €250 million, 67% of which is dedicated to targeted therapies in oncology.

The majority shareholder of Laboratoires Pierre Fabre is the Pierre Fabre Foundation (holding 86.3% of the capital), a humanitarian foundation recognized as being of public utility. The company’s employees are its second-largest shareholder (nearly 10%). This shareholding structure guarantees the company’s independence, its long-term vision and its sustainable contribution to the common good. Dividends paid to the Pierre Fabre Foundation contribute to 35 healthcare-access programs deployed in 22 of the least developed countries in the world.

Since 2023, Laboratoires Pierre Fabre’ CSR policy has been assessed by AFNOR Certification and has been awarded the “Exemplary” level of its CSR label (ISO 26 000 standard for sustainable development). For more information, visit www.pierre-fabre.com

Media Contact:
Beach House PR
avene@beachhousepr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/skincare-myths-are-going-viral-but-avene-is-empowering-dermatologists-to-lead-the-narrative-302879437.html

SOURCE Laboratoires Pierre Fabre

SAN DIEGO, Sept. 15, 2026 /PRNewswire/ — The Shareholders Foundation, Inc. announced that a lawsuit was filed for certain investors in shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT).

Investors who purchased shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) have certain options. NASDAQ: PRCT investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

On July 24, 2026, a NASDAQ: PRCT investor filed lawsuit over alleged securities laws violations by PROCEPT BioRobotics Corporation. 

The lawsuit seeks to recover losses for certain investors.

The plaintiff alleges that the defendants allegedly misrepresented and/or failed to disclose that PROCEPT BioRobotics Corporation utilized a discount program to incentivize customers to place bulk orders in excess of demand, that the undisclosed discount program artificially inflated the company’s reported U.S. handpiece unit sales, that the consistent surplus of U.S. handpiece unit sales results in overstocking and exposed PROCEPT BioRobotics Corporation to material undisclosed risks of operational and financial harm, and that as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Those who purchased shares of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares should contact the Shareholders Foundation, Inc.

CONTACT:
Shareholders Foundation, Inc. 
Michael Daniels 
+1 (858) 779-1554 
mail@shareholdersfoundation.com
3111 Camino Del Rio North 
Suite 423 
San Diego, CA 92108

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lawsuit-notice-nasdaq-prct-investors-who-lost-money-with-procept-biorobotics-corporation–shares-should-contact-the-shareholders-foundation-302879426.html

SOURCE Shareholders Foundation, Inc.